BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/23/2022 1:56:15 PM | Browse: 363 | Download: 777
 |
Received |
|
2022-05-24 16:40 |
 |
Peer-Review Started |
|
2022-05-19 10:38 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2022-08-22 00:44 |
 |
Revised |
|
2022-08-23 07:09 |
 |
Second Decision |
|
2022-09-27 03:50 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2022-10-04 22:40 |
 |
Articles in Press |
|
2022-10-04 22:40 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2022-09-15 18:20 |
 |
Typeset the Manuscript |
|
2022-11-11 15:55 |
 |
Publish the Manuscript Online |
|
2022-11-23 13:56 |
ISSN |
2220-3249 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Infectious Diseases |
Manuscript Type |
Letter to the Editor |
Article Title |
Global challenge with the SARS-CoV-2 omicron BA.2 (B.1.1.529.2) subvariant: Should we be concerned?
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Jalil Roohani and Masoud Keikha |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Masoud Keikha, Doctor, MD, Pediatric Gastroenterology Fellow, Department of Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Qoreishi Center, Daneshgah Street, Mashhad 13131-99137, Iran. masoud.keykha90@gmail.com |
Key Words |
SARS-CoV-2; Omicron; BA.2; B.1.1.529.2; Subvariant |
Core Tip |
BA.2 is novel omicron offshoot that goes viral. There is limit knowledge regarding this variant of concern. Current evidence suggested this variant is more contagious but less severe than previous severe acute respiratory syndrome coronavirus 2 previous variants. However, there is concern regarding the virus mutations that could be influenced pathogenicity, transmissibility as well as immune evasion. |
Publish Date |
2022-11-23 13:56 |
Citation |
Roohani J, Keikha M. Global challenge with the SARS-CoV-2 omicron BA.2 (B.1.1.529.2) subvariant: Should we be concerned? World J Virol 2022; 11(6): 496-501 |
URL |
https://www.wjgnet.com/2220-3249/full/v11/i6/496.htm |
DOI |
https://dx.doi.org/10.5501/wjv.v11.i6.496 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345